Insulin Clamp Ancillary Study for Assessment of Insulin Resistance

PHASE3CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 15, 2016

Study Completion Date

February 15, 2016

Conditions
Type 1 Diabetes
Interventions
DRUG

Metformin

The strength of each tablet will be 500 mg. Participants will build up to a daily dose over four weeks by taking one tablet per day for 7 days, one tablet twice daily for 7 days, one tablet in the morning and 2 tablets at night for 7 days, and then 2 tablets in the morning and 2 tablets at night, daily throughout the remainder of the study treatment period.

DRUG

Placebo

Trial Locations (1)

33647

Jaeb Center for Health Research, Tampa

All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

Jaeb Center for Health Research

OTHER